Cargando…
Functionally distinct regions of the locus Leishmania major response 15 control IgE or IFNγ level in addition to skin lesions
Leishmaniasis, a disease caused by parasites of Leishmania spp., endangers more than 1 billion people living in endemic countries and has three clinical forms: cutaneous, mucocutaneous, and visceral. Understanding of individual differences in susceptibility to infection and heterogeneity of its path...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437074/ https://www.ncbi.nlm.nih.gov/pubmed/37600780 http://dx.doi.org/10.3389/fimmu.2023.1145269 |
_version_ | 1785092430238842880 |
---|---|
author | Krayem, Imtissal Sohrabi, Yahya Havelková, Helena Gusareva, Elena S. Strnad, Hynek Čepičková, Marie Volkova, Valeryia Kurey, Iryna Vojtíšková, Jarmila Svobodová, Milena Demant, Peter Lipoldová, Marie |
author_facet | Krayem, Imtissal Sohrabi, Yahya Havelková, Helena Gusareva, Elena S. Strnad, Hynek Čepičková, Marie Volkova, Valeryia Kurey, Iryna Vojtíšková, Jarmila Svobodová, Milena Demant, Peter Lipoldová, Marie |
author_sort | Krayem, Imtissal |
collection | PubMed |
description | Leishmaniasis, a disease caused by parasites of Leishmania spp., endangers more than 1 billion people living in endemic countries and has three clinical forms: cutaneous, mucocutaneous, and visceral. Understanding of individual differences in susceptibility to infection and heterogeneity of its pathology is largely lacking. Different mouse strains show a broad and heterogeneous range of disease manifestations such as skin lesions, splenomegaly, hepatomegaly, and increased serum levels of immunoglobulin E and several cytokines. Genome-wide mapping of these strain differences detected more than 30 quantitative trait loci (QTLs) that control the response to Leishmania major. Some control different combinations of disease manifestations, but the nature of this heterogeneity is not yet clear. In this study, we analyzed the L. major response locus Lmr15 originally mapped in the strain CcS-9 which carries 12.5% of the genome of the resistant strain STS on the genetic background of the susceptible strain BALB/c. For this analysis, we used the advanced intercross line K3FV between the strains BALB/c and STS. We confirmed the previously detected loci Lmr15, Lmr18, Lmr24, and Lmr27 and performed genetic dissection of the effects of Lmr15 on chromosome 11. We prepared the interval-specific recombinant strains 6232HS1 and 6229FUD, carrying two STS-derived segments comprising the peak linkage of Lmr15 whose lengths were 6.32 and 17.4 Mbp, respectively, and analyzed their response to L. major infection. These experiments revealed at least two linked but functionally distinct chromosomal regions controlling IFNγ response and IgE response, respectively, in addition to the control of skin lesions. Bioinformatics and expression analysis identified the potential candidate gene Top3a. This finding further clarifies the genetic organization of factors relevant to understanding the differences in the individual risk of disease. |
format | Online Article Text |
id | pubmed-10437074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104370742023-08-19 Functionally distinct regions of the locus Leishmania major response 15 control IgE or IFNγ level in addition to skin lesions Krayem, Imtissal Sohrabi, Yahya Havelková, Helena Gusareva, Elena S. Strnad, Hynek Čepičková, Marie Volkova, Valeryia Kurey, Iryna Vojtíšková, Jarmila Svobodová, Milena Demant, Peter Lipoldová, Marie Front Immunol Immunology Leishmaniasis, a disease caused by parasites of Leishmania spp., endangers more than 1 billion people living in endemic countries and has three clinical forms: cutaneous, mucocutaneous, and visceral. Understanding of individual differences in susceptibility to infection and heterogeneity of its pathology is largely lacking. Different mouse strains show a broad and heterogeneous range of disease manifestations such as skin lesions, splenomegaly, hepatomegaly, and increased serum levels of immunoglobulin E and several cytokines. Genome-wide mapping of these strain differences detected more than 30 quantitative trait loci (QTLs) that control the response to Leishmania major. Some control different combinations of disease manifestations, but the nature of this heterogeneity is not yet clear. In this study, we analyzed the L. major response locus Lmr15 originally mapped in the strain CcS-9 which carries 12.5% of the genome of the resistant strain STS on the genetic background of the susceptible strain BALB/c. For this analysis, we used the advanced intercross line K3FV between the strains BALB/c and STS. We confirmed the previously detected loci Lmr15, Lmr18, Lmr24, and Lmr27 and performed genetic dissection of the effects of Lmr15 on chromosome 11. We prepared the interval-specific recombinant strains 6232HS1 and 6229FUD, carrying two STS-derived segments comprising the peak linkage of Lmr15 whose lengths were 6.32 and 17.4 Mbp, respectively, and analyzed their response to L. major infection. These experiments revealed at least two linked but functionally distinct chromosomal regions controlling IFNγ response and IgE response, respectively, in addition to the control of skin lesions. Bioinformatics and expression analysis identified the potential candidate gene Top3a. This finding further clarifies the genetic organization of factors relevant to understanding the differences in the individual risk of disease. Frontiers Media S.A. 2023-08-03 /pmc/articles/PMC10437074/ /pubmed/37600780 http://dx.doi.org/10.3389/fimmu.2023.1145269 Text en Copyright © 2023 Krayem, Sohrabi, Havelková, Gusareva, Strnad, Čepičková, Volkova, Kurey, Vojtíšková, Svobodová, Demant and Lipoldová https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Krayem, Imtissal Sohrabi, Yahya Havelková, Helena Gusareva, Elena S. Strnad, Hynek Čepičková, Marie Volkova, Valeryia Kurey, Iryna Vojtíšková, Jarmila Svobodová, Milena Demant, Peter Lipoldová, Marie Functionally distinct regions of the locus Leishmania major response 15 control IgE or IFNγ level in addition to skin lesions |
title | Functionally distinct regions of the locus Leishmania major response 15 control IgE or IFNγ level in addition to skin lesions |
title_full | Functionally distinct regions of the locus Leishmania major response 15 control IgE or IFNγ level in addition to skin lesions |
title_fullStr | Functionally distinct regions of the locus Leishmania major response 15 control IgE or IFNγ level in addition to skin lesions |
title_full_unstemmed | Functionally distinct regions of the locus Leishmania major response 15 control IgE or IFNγ level in addition to skin lesions |
title_short | Functionally distinct regions of the locus Leishmania major response 15 control IgE or IFNγ level in addition to skin lesions |
title_sort | functionally distinct regions of the locus leishmania major response 15 control ige or ifnγ level in addition to skin lesions |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437074/ https://www.ncbi.nlm.nih.gov/pubmed/37600780 http://dx.doi.org/10.3389/fimmu.2023.1145269 |
work_keys_str_mv | AT krayemimtissal functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions AT sohrabiyahya functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions AT havelkovahelena functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions AT gusarevaelenas functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions AT strnadhynek functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions AT cepickovamarie functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions AT volkovavaleryia functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions AT kureyiryna functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions AT vojtiskovajarmila functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions AT svobodovamilena functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions AT demantpeter functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions AT lipoldovamarie functionallydistinctregionsofthelocusleishmaniamajorresponse15controligeorifnglevelinadditiontoskinlesions |